Similarly, there is a trending increase in LAMP-2-ANCA titers in patients with worsening renal disease at 12 months, as determined by a decrease in GFR > 10 ml/min/1.73m2 (Figure 3C). This evidence concerns the gene LAMP2 and kidney disorder.